Tag: David Mooney
-
Science & Tech
Putting a crown on OMNIVAX
A biomaterials-based infection vaccine strategy shows first promise in eliciting immunity against SARS-CoV-2 and could be applied broadly to stave off infectious disease.
-
Health
A solid vaccine for liquid tumors
A new study presents an alternative treatment for acute myeloid leukemia (AML) that has the potential to eliminate AML cells completely.
-
Campus & Community
Wyss donates third major gift
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today the latest gift of $131 million from its founder, entrepreneur and philanthropist Hansjörg Wyss, M.B.A. ’65.
-
Health
Harnessing nature to beat cancer
Every year, more than 18 million people around the world are told, “You have cancer.” In the U.S., nearly half of all men and more than one-third of women will…
-
Science & Tech
Novel cancer treatment gets major boost
The Wyss Institute and Harvard John A. Paulson School of Engineering and Applied Sciences announced Novartis will have access to commercially develop their therapeutic, biomaterial-based cancer vaccine technology.
-
Science & Tech
Personal cancer vaccines show promise
Researchers have found that an injectable scaffold that incorporates tumor-specific peptides can be personalized, stimulating a patient’s immune system to destroy his or her unique cancer tumors.
-
Science & Tech
Mechanical stimulation shown to repair muscle
Harvard research teams find a promising new approach that uses direct mechanical stimulation to repair severely damaged skeletal muscles.
-
Campus & Community
Sharp messages
Poet Kay Ryan and former Harvard President Derek Bok blended wit and wisdom in addressing top-ranked seniors at the 222nd Phi Beta Kappa Literary Exercises on May 22.
-
Campus & Community
Faculty honored with PBK Teaching Prizes
The Phi Beta Kappa Alpha Iota Chapter of Massachusetts announced three recipients of the Phi Beta Kappa Prize in Excellence in Teaching for this academic year.
-
Campus & Community
Bench to Bedside – Innovation at Harvard
Harvard researchers and clinicians collaborate across disciplines and around the globe to craft solutions to the world’s toughest health challenges.
-
Science & Tech
Squeezing life into patients
Engineers at Duke and Harvard universities have developed a “magnetic sponge” that after implantation into a patient can “squeeze” out drugs, cells, or other agents when passed over by a magnet.
-
Campus & Community
David Mooney elected to NAE
David J. Mooney, a professor at Harvard’s School of Engineering and Applied Sciences, has been elected to the National Academy of Engineering.
-
Health
First cancer vaccine to eliminate tumors in mice
A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, a team of Harvard bioengineers and biologists report…
-
Science & Tech
Implants mimic infection to rally immune system against tumors
Harvard bioengineers have shown that small plastic disks impregnated with tumor-specific antigens and implanted under the skin can reprogram the mammalian immune system to attack tumors. The research — which…
-
Science & Tech
Hansjorg Wyss gives $125 million to create institute for biologically inspired engineering
Engineer, entrepreneur, and philanthropist Hansjörg Wyss MBA ’65 has given Harvard University $125 million to create the Hansjörg Wyss Institute for Biologically Inspired Engineering. Investigators at the Wyss Institute (pronounced…
-
Science & Tech
Harvard science depth, breadth is on display
Five prominent Harvard scientists illuminated the cutting edge of Harvard science, predicting new treatments for old diseases, describing new ways to think about the universe, and hailing advances in our…
-
Campus & Community
Transplanted cells regenerate muscles
Biological engineering, which once excited the medical community, has been fraught with the difficulties of keeping transplanted cells alive and getting them to integrate with a host’s body. Researchers at…